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Objectives This study sought to determine the prevalence of lipid and lipoprotein abnormalities and their association with
the risk of a first acute myocardial infarction (AMI) among Asians.
Background Patterns of lipid abnormalities among Asians and their relative impact on cardiovascular risk have not been well
characterized.
Methods In a case-control study, 65 centers in Asia recruited 5,731 cases of a first AMI and 6,459 control subjects.
Plasma levels of lipids and apolipoproteins in the different Asian subgroups (South Asians, Chinese, Southeast
Asians, and Japanese) were determined and correlated with the risk of AMI.
Results Among both cases and controls, mean low-density lipoprotein cholesterol (LDL-C) levels were about 10 mg/dl
lower in Asians compared with non-Asians. A greater proportion of Asian cases and controls had LDL-C 100
mg/dl (25.5% and 32.3% in Asians vs. 19.4% and 25.3% in non-Asians, respectively). High-density lipoprotein
cholesterol (HDL-C) levels were slightly lower among Asians compared with non-Asians. There was a preponder-
ance of people with low HDL-C among South Asians (South Asia vs. rest of Asia: cases 82.3% vs. 57.4%; controls
81% vs. 51.6%; p  0.0001 for both comparisons). However, despite these differences in absolute levels, the
risk of AMI associated with increases in LDL-C and decreases in HDL-C was similar for Asians and non-Asians.
Among South Asians, changes in apolipoprotein (Apo)A1 predicted risk better than HDL-C. ApoB/ApoA1 showed
the strongest association with the risk of AMI.
Conclusions The preserved association of LDL-C with risk of AMI among Asians, despite the lower baseline levels, suggests
the need to rethink treatment thresholds and targets in this population. The low HDL-C level among South
Asians requires further study and targeted intervention. (J Am Coll Cardiol 2009;53:244–53) © 2009 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.09.041c
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January 20, 2009:244–53 Lipids and Risk of AMI in Asianserived from studies in the Caucasian population. The
attern of lipid abnormalities and their relative impact on
VD risk might vary among ethnic groups (2–8). Asians
xperience the largest proportion of the worldwide burden
f CVD. Further, Asians include several distinct ethnic
ubpopulations (South Asians, Chinese, etc.), who may
iffer in their lipid profiles (3). These differences may be
he result of both genetic and environmental factors
high-carbohydrate diets, reduced physical activity, and
o on) (9,10).
There is also considerable controversy regarding the
elative importance of the apolipoprotein measures (ApoB
nd ApoAI) in comparison to the conventionally measured
ipid fractions in determining CVD risk, with practically
o data in Asian populations (11–13). The higher prev-
lence of hypertriglyceridemia and small, dense LDL-C
articles among some Asian subgroups raises the possi-
ility that lipoprotein levels will more accurately reflect
he total atherogenic particle load, and consequently,
VD risk (14,15).
The INTERHEART study, which enrolled over 5,500
ases of a first acute myocardial infarction (AMI) and nearly
,500 control subjects from Asia, and measured both li-
oproteins and apolipoproteins, provides an opportunity to
xplore the relative importance of these markers and the risk
f AMI in Asians.
ethods
he INTERHEART study is a case-control study that
nrolled 15,152 cases of a first AMI and 14,820 age- (5
ears) and sex-matched control subjects from 262 centers in
2 countries. The details of the study methods, inclusion
nd exclusion criteria, and the overall results have been
ublished and are also described in the Online Appendix
16–18). This analysis pertains to the individuals who were
ecruited from 65 centers in countries from Asia. India,
akistan, Bangladesh, Nepal, and Sri Lanka represented the
outh Asian region. The Southeast Asian countries in-
luded were Singapore, Malaysia, Thailand, and the Phil-
ppines. The other countries included in this analysis were
hina and Hong Kong, and Japan.
ubjects and study procedures. Centers in Asia recruited
,731 cases of AMI and 6,459 control subjects. All patients
dmitted to the hospital with a diagnosis of a first AMI,
ithin 24 h of the initial symptoms, were eligible for
nrollment. Control subjects were either hospital based
patients admitted to hospital with a noncardiac diagnosis)
r community based (unrelated attendants of index patients,
ttendants of noncardiac patients). Control subjects neither
ad a history of exertional chest pain nor were known to
ave cardiac disease. Nonfasting blood samples were ob-
ained from case and control subjects, and the time since the
ast meal and from the onset of symptoms was documented.
lood samples were obtained and centrifuged within 2 h,eparated, and immediately frozen at either 20°C or at A70°C. Samples were periodi-
ally shipped in nitrogen vapor
anks for storage at 80°C in
hina or at 160°C in Hamil-
on, Ontario, Canada. The lab-
ratory procedures involved in
ipid and lipoprotein measure-
ent have been detailed else-
here (18) and also in the On-
ine Appendix.
tatistical analysis. Continuous
ariables were summarized using
eans and were compared using
nalysis of variance model-based
ests. For comparison of means across subgroups, values
ere adjusted for age and sex using analysis of covariance
odels. Univariate associations were explored using fre-
uency tables and Pearson chi-square tests for independent
roportions. Unconditional logistic regression with adjust-
ent for matching factors was used to control for confound-
ng by other risk factors. Results from unconditional anal-
ses were similar to those from conditional and mixed-effect
odels analyses (5% variation). The results were consis-
ent using the 2 types of controls, and so the results are
resented using the overall analysis. All statistical tests were
-sided. Statistical analyses were performed using the SAS
ystem version 9.1 (SAS Institute Inc., Cary, North Carolina).
ll of our models were multivariate, and in general we adjusted
or age, sex, smoking, and geographic region.
esults
ata for LDL-C and high-density lipoprotein cholesterol
HDL-C) were available for 4,247 cases and 5,452 control
ubjects from Asia. Lipid data were available for 4,455 cases
nd 5,867 control subjects from other regions of the world.
issing samples were largely accounted for by patients who
resented 24 h after the onset of symptoms (in whom blood
as not drawn) and unusable samples (because of poor
torage and unclear labeling). The proportion of missing
amples among Asians was similar to that in the overall
NTERHEART population (18). Non-Asians were more
ikely to be diabetic, to be hypertensive, and to have
bdominal obesity, but were also more likely to exercise and
o consume fruits and vegetables and alcohol regularly.
sians were more likely to be smokers (Online Appendix).
ifferences in lipid and lipoprotein levels among Asians
nd non-Asians. The mean LDL-C level (mg/dl) was
ignificantly lower among both Asian cases (126.8 vs. 136.2)
nd control subjects (118.7 vs. 127.1; p  0.0001 for both
omparisons) compared with non-Asians (Table 1). Fur-
her, a larger proportion of Asians had a low LDL-C level.
he proportion of cases and control subjects from Asia who
ad LDL-C levels 100 mg/dl was 25.5% and 32.3%
espectively, compared with 19.4% and 25.3% in non-
Abbreviations
and Acronyms
AMI  acute myocardial
infarction
Apo  apolipoprotein
CVD  cardiovascular
disease
HDL-C  high-density
lipoprotein cholesterol
LDL-C  low-density
lipoprotein cholesterol
TG  triglyceridesians (Table 2), with consistent results in both sexes and in
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Lipids and Risk of AMI in Asians January 20, 2009:244–53ll age groups. Levels of HDL-C and triglycerides (TGs)
ere lower among Asians (Table 1). The ApoB levels were
lso lower among Asians than among subjects from other
egions of the world, whereas ApoA1 levels were similar
etween the 2 populations (Table 1).
DL-C, HDL-C, TG, and Apo levels among Asian
ubgroups. There were large variations in the LDL-C
evels among the various Asian subgroups. South Asians and
eople from China and Hong Kong tended to have lower
DL-C levels compared with people from Southeast Asia
nd Japan (Table 1). This was because of the higher
revalence of people with LDL-C levels 100 mg/dl
mong South Asians and the Chinese (Table 2). The
bsolute differences in LDL-C levels were large and were
bout 30 mg/dl lower among people from China and Hong
ong compared with those from Southeast Asia. Southeast
sians had LDL-C levels similar to people from other
on-Asian regions. The Japanese also had LDL-C levels
imilar to non-Asian people, but this observation was based
n a relatively small number of subjects (n  247) (Tables
and 2).
The HDL-C levels in the South Asian population were
ubstantially lower than in all other subgroups (Tables 1 and
). Over 80% of both cases and control subjects in South
sia had low HDL-C levels (cases 82.3% vs. 57.4%; control
ubjects 81% vs. 51.6%; comparisons between South Asia
nd the rest of Asia; p  0.0001 for both comparisons)
Table 2). The proportion of people with low HDL-C
evels in the other Asian subgroups tended to be similar to
r lower than in non-Asians. Japanese control subjects
eemed to have a preponderance of normal or high HDL-C
evels, but again, this observation is based on a small number
f subjects (Table 2).
People from China and Hong Kong had the lowest TG
evels, and South Asians had the highest (difference of 10
g/dl) (Table 1). Whereas the former had lower TG levels
hen compared with people from other continents, the
atter had comparable or marginally higher levels (Table 1).
he TG levels among Southeast Asians and the Japanese
ere closer to the levels found in non-Asians.
The ApoB levels were lowest among people from China
nd Hong Kong. People from the other Asian regions had
evels similar to those in the rest of the world. The
ssociation between LDL-C and ApoB levels was linear,
nd increases in LDL-C were associated with predictable
ncreases in ApoB among all subjects. However, the abso-
ute values corresponding to different LDL-C levels differed
mong subgroups. For any given LDL-C level, South
sians had the highest and the Chinese had the lowest
poB levels when compared with the other Asian sub-
roups (Fig. 1A).
The ApoA1 levels were lowest among South Asians. The
ssociation between HDL-C and ApoA1 levels was linear
or all populations, and higher HDL-C levels were associ-
ted with predictably higher ApoA1 levels. However,among South Asians, for any given HDL-C level, theT
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January 20, 2009:244–53 Lipids and Risk of AMI in Asiansorresponding ApoA1 level was lower than in the other
opulations (p for heterogeneity 0.0001) (Fig. 1B).
DL-C, HDL-C, Apo, and risk of AMI. The risk of
MI increased progressively with elevations in LDL-C levels
mong Asian subjects as a whole and across all subgroups of
he Asian population (Fig. 2). The higher risk associated with
levations in LDL-C levels was similar to that observed in the
est of the INTERHEART population.
As in subjects from other regions of the world, elevations
n HDL-C were associated with a decreased risk of AMI
Fig. 3). This lower risk was of a similar magnitude to that
bserved in other populations and was consistent across all
f the Asian subgroups. However, the protective effect of
igher HDL-C levels seemed to be weaker for South
sians compared with the other Asians (odds ratio [OR]
or 1 SD increase in South Asians: 0.87, 95% confidence
nterval [CI]: 0.72 to 1.06; OR for rest of Asia: 0.77, 95%
I: 0.70 to 0.85; p for interaction  0.25). In every
DL-C category, subjects with a normal or high HDL-C
ad a lower risk of AMI than those with low HDL-C
evels. (Fig. 4).
The risk of AMI for 1 SD increase in ApoB levels was
imilar in magnitude to that associated with a similar
ncrease in LDL-C (ORs: 1.24 and 1.25, respectively).
ncreases in ApoA1 levels were associated with a lower risk of
MI (OR for 1 SD increase: 0.65, 95% CI: 0.62 to 0.68),
hich was significantly greater than that observed with
DL-C. Further, increases in ApoA1 were equally protective
mong all of the Asian subgroups, unlike increases in HDL-C.
mong South Asians, the lower risk of AMI associated with
igh ApoA1 levels was similar to that observed overall (OR:
.67, 95% CI: 0.61 to 0.74).
omparison of AMI risk by lipid and Apo ratios. The
atio of ApoB and ApoA1 had the strongest association
ith the risk of AMI among Asians and non-Asians.
mong Asians, for a 1-SD increase in the ratio, the OR
or AMI was 1.38, compared with an OR of 1.06 and
.14 for every SD increase in the non–HDL-C/HDL-C
nd LDL-C/HDL-C ratios, respectively (Fig. 5). In-
reases in non–HDL-C and LDL-C were associated
ith much smaller ORs than for increases in the ApoB/
poA1 ratio. Fasting TG levels (samples drawn 8 h
fter the last meal) were not associated with an increase
n the risk of AMI; neither was the TG/HDL-C ratio.
iscussion
ur data suggests that: 1) LDL-C, HDL-C, TG, and
poB levels are lower among Asians compared with non-
sians. However, there is much heterogeneity among the
arious subgroups of the Asian population, with lower levels
f HDL-C and LDL-C in South Asians and lower levels of
DL-C among the Chinese. 2) The associations of elevatedLDL-C and lower levels of HDL-C for the risk of AMI are
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Lipids and Risk of AMI in Asians January 20, 2009:244–53roadly similar among Asians and non-Asians. 3) As in the
verall INTERHEART population, the ratio of ApoB to
poA1 had the strongest association with the risk of AMI
n Asians.
igher prevalence of low LDL-C levels among people of
hinese and South Asian origin. More than one-fourth
f the patients with AMI from South Asia and China had
Figure 1 Regression Plots
(A) Regression plot of age- and sex-adjusted apolipoprotein (Apo)B versus low-den
Asians had the highest ApoB levels and the Chinese had the lowest. (B) Regressi
(HDL-C) by ethnic group. For any given HDL-C level, South Asians had the lowest Aevels of LDL-C 100 mg/dl, whereas the proportions of seople from Southeast Asia and Japan with low LDL-C
evels resembled the rest of the INTERHEART population
rom other continents. The mean LDL-C level in the Asia
acific collaboration study was 3.23 mmol/l (125 mg/dl),
hich is similar to the mean LDL-C level among cases in
ur analysis (8). The low mean level of LDL-C observed in
ur analysis is also consistent with several other cross-
oprotein cholesterol (LDL-C) by ethnic group. For any given LDL-C level, South
t of age- and sex-adjusted ApoA1 versus high-density lipoprotein cholesterol
evels compared with all of the other subgroups.sity lip
on plo
poA1 lectional studies from Asia (2,5,19,20).
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January 20, 2009:244–53 Lipids and Risk of AMI in AsiansThe reasons for low LDL-C levels among Asians are
nknown. Lower levels of LDL-C and other lipid fractions
ight simply be a function of lower body mass. Indeed, a
urvey of Japanese men and women indicated that at the
ower end of the body mass index spectrum, serum choles-
erol levels were much lower than in the average Western
opulation, but as body mass index increased toward the
estern average, so did the lipid levels (21). In our analysis,
LDL 
Categories 
(mg/dL) 
Control 
N (%) 
Cases 
N (%) 
Odds R
(95% C
≤100 1763 (32.3) 1084 (25.5)
>100, ≤130 1852 (33.9) 1391 (32.7) 1.17 
>130, ≤160 1140 (20.9) 1019 (24.0) 1.44 
>160 701 (12.9) 754 (17.8) 1.92 
Figure 2 ORs for Risk of First AMI With Increasing LDL-C Level
Increasing LDL-C levels are associated with progressively increasing odds of a firs
For conversion of LDL-C levels into mmol/l, multiply by 0.0259. AMI  acute myoc
OR  odds ratio.
HDL 
Categories 
(mg/dL) 
Control 
N (%) 
Cases 
N (%) 
Odds Ratio
(95% CI) 
<40 3043 (53.5) 2567 (58.1) 1 
40-50 1374 (24.2) 1094 (24.8) 0.85 (0.74
>50 1272 (22.4) 758 (17.2) 0.69 (0.60
Figure 3 ORs for Risk of First AMI With Increasing HDL-C Leve
Increasing HDL-C levels are associated with a progressive decrease in the odds of
for age and sex. For conversion of HDL-C levels into mmol/l, multiply by 0.0259. However, LDL-C levels among Asians remained lower even
fter adjustment for waist-hip ratio and body mass index.
Although the LDL-C levels in our study (which were
alculated using the Friedwald formula) could be artifactu-
lly lower by the elevated TG levels because of a nonfasting
tate, this is unlikely to be a major confounder for 2 reasons.
irst, separate analyses of patients who had their last meal
ore than 8 h before blood sampling (which approximates
 
-1.34)
-1.67)
-2.28)
ong Asian Subjects
mong Asian subjects. *OR adjusted for age and sex.
infarction; CI  confidence interval; LDL-C  low-density lipoprotein cholesterol;
)
)
ong Asian Subjects
t AMI among Asian subjects. *ORs adjusted
 high-density lipoprotein cholesterol; other abbreviations as in Figure 2.atio*
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Lipids and Risk of AMI in Asians January 20, 2009:244–53n overnight fast) indicates results that were consistent with
he overall analysis. Second, the overall mean TG levels in
ur study were not elevated (and in some subgroups, were
ctually lower) compared with previous studies among
sians.
Despite the lower absolute levels, however, the risk of
MI was proportionately higher with higher LDL-C,
ith similar patterns in all of the Asian subgroups. The
agnitude of risk increase associated with a 1-SD in-
rease in LDL-C levels in our study is consistent with the
ncrease in risk (hazard ratio: 1.35) of coronary heart
isease–related death observed in the Asia–Pacific cohort
tudy (8). This implies that, for a given LDL-C level, the
isk of AMI may be higher among Asians compared with
on-Asian populations. This finding has been a recurring
heme in studies involving South Asians (2,5,19,20). This
ifference in atherogenicity of LDL-C in this population
as been attributed to differences in particle size and
ensity, with smaller and denser particles being more
therogenic (22). Indeed, studies among Asian Indians
ave shown a higher prevalence of small, dense LDL-C
articles in this population compared with Caucasians
23). We did not estimate LDL-C particle size among
ur patients. Moreover, whether this explanation can be
xtrapolated to the other ethnically distinct Asian popu-
ations is not clear.
poB levels among Asians. Subjects from China and
ong Kong had the lowest ApoB levels, accounting for
he lower mean levels among Asians compared with
LDL And HDL 
Categories 
(mg/dL) 
Control 
N (%) 
Cases 
N (%) 
Odds R
(95% 
LDL ≤100 
HDL M<40 F<50 
1105 (20.3) 728 (17.1) 1 
LDL ≤100 
HDL M≥40 F≥50 
655 (12.0) 356 (8.9) 0.79 (0.67
LDL >100, ≤130 
HDL M<40 F<50 
1059 (19.4) 865 (20.4) 1.27 (1.12
LDL >100, ≤130 
HDL M≥40 F≥50
792 (14.5) 525 (12.4) 0.99 (0.85
LDL >130, ≤160 
HDL M<40 F<50 
637 (11.7) 629 (14.8) 1.61 (1.39
LDL >130, ≤160 
HDL M≥40 F≥50
503 (9.2) 390 (9.2) 1.22 (1.03
LDL >160 
HDL M<40 F<50 
395 (7.3) 468 (11.0) 2.10 (1.78
LDL >160 
HDL M≥40 F≥50
306 (5.6) 286 (6.7) 1.53 (1.27
Figure 4 ORs for Risk of First AMI in Different LDL-C Categorie
For any given LDL-C category, a normal or high HDL-C level is associated with a lo
for age and sex. For conversion of LDL-C and HDL-C levels into mmol/l, multiply byeople from other regions of the world. The low ApoB sevels paralleled the low LDL-C levels in this population
Table 1, Fig. 1) On the other hand, among South
sians, who had LDL-C levels that were similar to the
hinese, ApoB levels were much higher, presumably
ndicating a larger atherogenic particle load and possibly
maller LDL-C particle size (Fig. 1).
DL-C and ApoA1 levels among Asians. South Asians
ad HDL-C levels that were on average 10 mg/dl lower
han those in the rest of the Asian population and other
on-Asian groups. This was accompanied by lower ApoA1
evels. This predilection of South Asians to have lower
DL-C levels is well known (2), and has been attributed to
he higher prevalence of insulin resistance and related
etabolic abnormalities, which may be the consequence of
combination of genetic predisposition, physical inactivity,
nd a high-carbohydrate diet (2,9,10). By contrast, among
ther Asian subgroups, HDL-C levels were higher and
imilar to levels in non-Asians. Polymorphisms of the genes
egulating cholesteryl ester transfer protein (CETP) are also
nown to affect HDL-C levels. But the interplay of these
olymorphisms, HDL-C levels, and CVD risk among
sians is poorly understood (24).
Higher levels of HDL-C were associated with equiv-
lent protection from AMI in Asians and non-Asians.
owever, among South Asians, we observed a nonsig-
ificant tendency toward weaker protection afforded by
ormal or high levels of HDL-C. Other investigators
ave shown a similar lack of protective effect of HDL-C
mong Asian Indians. In a community-based cross-
0.5 421
OR ( 95% CI )
usted to HDL-C Levels Among Asian Subjects
ds of a first AMI. *ORs adjusted
59. F  female; M  male; other abbreviations as in Figures 1 and 2.atio*
CI) 
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-1.14)
-1.86)
-1.43)
-2.49)
-1.86)
s Adj
wer od
0.02ectional study correlating risk factors with carotid
i
a
I
p
v
t
l
H
i
l
p
w
e
l
c
c
w
A
a
s
t
T
a
r
t
a
T
A
a
m
R
t
s
a
i
a
a
A
a
m
f
s
c
s
p
251JACC Vol. 53, No. 3, 2009 Karthikeyan et al.
January 20, 2009:244–53 Lipids and Risk of AMI in Asiansntima-media thickness, higher HDL-C levels were not
ssociated with lower intima-media thickness among
ndians, as was observed in a comparator (Caucasian)
opulation (25). Differences in the prevalence of the
arious HDL-C subfractions may account for some of
hese differences in CVD risk. At any given HDL-C
evel, Asian Indians have a higher prevalence of small
DL-C particles compared with Caucasians (26). Stud-
es have suggested that smaller HDL-C particles have
ower free cholesterol content, may be markers of im-
aired reverse cholesterol transport, and are associated
ith the presence of coronary artery disease (27). Inter-
stingly, higher HDL-C levels were accompanied by
ower absolute ApoA1 levels among South Asians when
ompared with other Asian populations (Fig. 1B). This
ould account for some of the lack of benefit observed
ith high HDL-C levels in this population. Higher
poA1 levels, on the other hand, were just as protective
mong South Asians as in the overall Asian population,
uggesting that it might be a better marker of AMI risk
han HDL-C in this subgroup.
G levels among Asians. The TG levels were lower
Figure 5 Risk of First AMI for 1-SD Change in the Various Lipid
Comparison of the odds of a first AMI with 1 SD change in the levels of LDL-C, no
ApoA1 ratio. The ApoB to ApoA1 ratio was associated with the greatest increase i
abdominal obesity, fruit and vegetable intake, exercise, alcohol consumption, andmong Asians by about 15 mg/dl when compared with the aest of the INTERHEART population. However, most of
his difference was caused by the low TG levels in China
nd Hong Kong. South Asians and Southeast Asians had
G levels similar to other non-Asian populations. The
sian cohort of the Asia-Pacific cohort studies (comprising
large number of Chinese subjects) also found a similar, low
ean TG level (28).
isk of AMI by lipid and Apo fractions. As in the rest of
he INTERHEART population, the ApoB/ApoA1 ratio
howed the strongest association with the risk of AMI
mong Asians. The stronger association is thought primar-
ly to be caused by the ability of the ApoB/ApoA1 ratio to
ccount for all of the atherogenic particles in plasma. Each
therogenic lipoprotein particle contains 1 molecule of
poB; therefore, plasma ApoB best estimates the total
therogenic particle number. LDL-C accounts for the vast
ajority of atherogenic particles and therefore has been the
undamental index of atherogenic risk. However, when
mall, dense, cholesterol-depleted LDL-C particles are
ommon, as is presumably the case among some Asian
ubgroups, LDL-C levels underestimate the atherogenic
article number. Further, ApoB is also present in other
Apo Parameters and Ratios
-C, the LDL-C to HDL-C ratio, the non–HDL-C to HDL-C ratio, and the ApoB to
dds of an AMI. *ORs adjusted for age, sex, smoking, diabetes, hypertension,
osocial index. Abbreviations as in Figures 1, 2, and 4.and
n–HDL
n the o
psychtherogenic lipid fractions such as very-low-density and
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Lipids and Risk of AMI in Asians January 20, 2009:244–53ntermediate-density lipoproteins, which again may be
resent in higher concentrations in these populations and is
ot represented in the LDL-C measure (29). The LDL-C/
DL-C ratio was not better than LDL-C alone in predict-
ng risk for the same reasons. Non–HDL-C has often been
sed as a surrogate measure of circulating atherogenic
ipoproteins. However, similar to some previous reports
14), we found that neither the increases in non–HDL-C
or the increases in the non–HDL-C/HDL-C ratio were as
trongly associated with the risk of AMI as the ApoB/
poA1 ratio.
The TG/HDL-C ratio was even less discriminatory. An
arlier study indicated that the TG/HDL-C ratio might be
ne of the best predictors of coronary artery disease-related
eath (8). However, this study also showed that TG levels
ere independent predictors of risk. We were, however,
nable to show that TG or any of the TG-related ratios
redicted AMI risk.
tudy strengths and limitations. The principal strengths
f our study are the large number of cases studied and the
eographic and ethnic diversity within Asians represented in
ur study population. The large number of cases from
everal subgroups of Asians provides statistical power to
xplore the strength of association of closely related lipid
arameters with the occurrence of a first AMI. However, we
ave refrained from performing too many subgroup analyses
o as to avoid potentially spurious associations, and have
een careful not to draw conclusions based on subgroups
e.g., the Japanese) with small numbers of subjects. We have
lso, for the first time, studied the association of lipoprotein
ractions to AMI risk among Asian subjects. However, one
mportant limitation of our analysis needs to be highlighted.
lood samples in the INTERHEART study were not
asting samples. However, measurements of ApoB and
poA1 are recognized as being relatively unaffected by the
onfasting state. Also, total cholesterol and HDL-C change
ittle after a meal. For the analysis of association of TG
evels to the risk of AMI, we included only those samples
hat were obtained at least 8 h after the last meal. Acute
yocardial infarction itself can alter serum lipid levels, but
hese changes occur after 48 h (30) and are not likely to
ffect the findings of our study because blood samples were
rawn within 24 h of symptom onset in 87.3% of our AMI
atients and within 48 h in 95.7% of them. Finally,
lthough the case-control design of our study may introduce
ome potential biases, we minimized this risk by careful
election of control subjects, by using standardized methods
f data collection for both cases and control subjects, and by
nly enrolling cases with a first AMI. Cases with a first
MI are less likely to have altered their lifestyle and diet
efore this event, thus ensuring lipid levels that might be
easonably representative of this population. Moreover, only
.2% of cases and 2.2% of control subjects were on lipid-
owering medications at the time of enrollment.
1onclusions and Clinical Implications
espite a higher prevalence of low LDL-C levels among
sians, the association of LDL-C levels with the risk of
MI was preserved. Overall, changes in levels of HDL-C
ere associated with changes in risk of AMI, which were
imilar across all regions of the world. Among South
sians, there was a preponderance of people with low
DL-C levels, and changes in ApoA1 levels were better
eterminants of risk than changes in HDL-C levels. Of
he various markers evaluated, the ApoB/ApoAI ratio
ad the strongest association with the risk of a first AMI.
tudies relating the particle size of HDL-C and LDL-C
nd their subtypes may further refine risk predictions.
lthough Asian patients are likely to benefit from low-
ring LDL-C, the threshold for treatment initiation and
he treatment targets are conceivably lower than for
aucasians. These thresholds and targets need to be
etermined in future studies. Finally, given the lower
evels of HDL-C among South Asians, approaches to
ncreasing HDL-C may also be beneficial in this
opulation.
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APPENDIX
or further details regarding the study subjects and methods, please see
he online version of this article.
